Alon Ben-Noon
Chief Executive Officer · NeuroSense Therapeutics Ltd.
- 2026
- Jun 17, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Alon Ben-Noon files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Or Eisenberg - $200K in NRSN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Alon Ben-Noon?
Alon Ben-Noon is a corporate insider, tracked as Chief Executive Officer of NeuroSense Therapeutics Ltd. (NRSN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Alon Ben-Noon last file a Form 4?
The only primary Form 4 on record is dated 17 June 2026.
Has Alon Ben-Noon been buying or selling stock?
Recorded transactions: 1 open-market purchase ($200K) and 0 open-market sales across all tracked filings.
